Healthcare Pathogen Detection System
Hospital-Acquired Infections (e.g., MRSA, C. diff)
Development/ValidationActive
Key Facts
Indication
Hospital-Acquired Infections (e.g., MRSA, C. diff)
Phase
Development/Validation
Status
Active
Company
About Seraph Biosciences
Seraph Biosciences is a private, pre-revenue diagnostics company leveraging a proprietary platform of spectroscopy and AI for rapid pathogen identification. Its core value proposition is enabling near real-time detection of infectious agents at the point-of-need, targeting critical gaps in hospital-acquired infection control and food supply chain monitoring. The company appears to be in a development and validation stage, positioning itself in the growing market for rapid diagnostics. As a private entity with limited publicly available data, its progress is likely tied to securing non-dilutive funding, strategic partnerships, and successful clinical validation of its systems.
View full company profile